Atlas Trials

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Clinical trial NCT00948909 · COMPLETED

Trial details

NCT number
NCT00948909
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2009-10-01
Primary completion
2010-11-01
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.